Stada And Alvotech Eye Potential EU Ustekinumab Nod This Year

A Frontrunner Filing For A Stelara Biosimilar Has Been Accepted For Review By The EMA

 
• By David Wallace
EMA
The EMA is examining Alvotech and Stada’s ustekinumab filing

More from Biosimilars

More from Products